These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 25880792)

  • 1. Polycomb repressive complex 2 epigenomic signature defines age-associated hypermethylation and gene expression changes.
    Dozmorov MG
    Epigenetics; 2015; 10(6):484-95. PubMed ID: 25880792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct chromatin signatures of DNA hypomethylation in aging and cancer.
    Pérez RF; Tejedor JR; Bayón GF; Fernández AF; Fraga MF
    Aging Cell; 2018 Jun; 17(3):e12744. PubMed ID: 29504244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
    Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model for transmission of the H3K27me3 epigenetic mark.
    Hansen KH; Bracken AP; Pasini D; Dietrich N; Gehani SS; Monrad A; Rappsilber J; Lerdrup M; Helin K
    Nat Cell Biol; 2008 Nov; 10(11):1291-300. PubMed ID: 18931660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
    Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ
    Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter histone H3K27 methylation in the control of IGF2 imprinting in human tumor cell lines.
    Li T; Chen H; Li W; Cui J; Wang G; Hu X; Hoffman AR; Hu J
    Hum Mol Genet; 2014 Jan; 23(1):117-28. PubMed ID: 23962719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of automethylated PRC2 by dimerization on chromatin.
    Sauer PV; Pavlenko E; Cookis T; Zirden LC; Renn J; Singhal A; Hunold P; Hoehne-Wiechmann MN; van Ray O; Kaschani F; Kaiser M; Hänsel-Hertsch R; Sanbonmatsu KY; Nogales E; Poepsel S
    Mol Cell; 2024 Oct; 84(20):3885-3898.e8. PubMed ID: 39303719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of CD11b transcription by decreasing PRC2 and increased acH4 level during ATRA-induced HL-60 differentiation.
    Tang H; Chen F; Tan Q; Tan S; Liu L; Zhang F
    Acta Biochim Biophys Sin (Shanghai); 2009 Jul; 41(7):588-93. PubMed ID: 19578722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycomb Repressive Complex 2 in Oncology.
    Guo Y; Yu Y; Wang GG
    Cancer Treat Res; 2023; 190():273-320. PubMed ID: 38113005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine leads to global genome changes in H3K27me3 levels via a Polycomb Repressive Complex 2 (PRC2) self-regulatory mechanism in mESCs.
    Muñoa-Hoyos I; Halsall JA; Araolaza M; Ward C; Garcia I; Urizar-Arenaza I; Gianzo M; Garcia P; Turner B; Subirán N
    Clin Epigenetics; 2020 Nov; 12(1):170. PubMed ID: 33168052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor SUZ12 in colon cancer cells.
    Wang H; Ge S; Qian G; Li W; Cui J; Wang G; Hoffman AR; Hu JF
    Exp Cell Res; 2015 Nov; 338(2):214-21. PubMed ID: 26407907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells.
    Neri F; Incarnato D; Krepelova A; Rapelli S; Pagnani A; Zecchina R; Parlato C; Oliviero S
    Genome Biol; 2013 Aug; 14(8):R91. PubMed ID: 23987249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML.
    Paul TA; Bies J; Small D; Wolff L
    Blood; 2010 Apr; 115(15):3098-108. PubMed ID: 20190193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenomic Regulation of Schwann Cell Reprogramming in Peripheral Nerve Injury.
    Ma KH; Hung HA; Svaren J
    J Neurosci; 2016 Aug; 36(35):9135-47. PubMed ID: 27581455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRC2 Components Maintain DNA Hypermethylation of the Upstream Promoter and Regulate Robo4 Expression in Endothelial Cells.
    Izawa K; Shirakura K; Kakiuchi K; Funahashi N; Maekawa N; Hino N; Tanaka T; Doi T; Okada Y
    Biol Pharm Bull; 2020; 43(4):742-746. PubMed ID: 32238717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of Polycomb Repressive Complex 2 to RNA by Short Repeats of Consecutive Guanines.
    Wang X; Goodrich KJ; Gooding AR; Naeem H; Archer S; Paucek RD; Youmans DT; Cech TR; Davidovich C
    Mol Cell; 2017 Mar; 65(6):1056-1067.e5. PubMed ID: 28306504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons.
    Henriquez B; Bustos FJ; Aguilar R; Becerra A; Simon F; Montecino M; van Zundert B
    Mol Cell Neurosci; 2013 Nov; 57():130-43. PubMed ID: 23932971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inner workings and regulatory inputs that control Polycomb repressive complex 2.
    O'Meara MM; Simon JA
    Chromosoma; 2012 Jun; 121(3):221-34. PubMed ID: 22349693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2).
    Xu C; Bian C; Yang W; Galka M; Ouyang H; Chen C; Qiu W; Liu H; Jones AE; MacKenzie F; Pan P; Li SS; Wang H; Min J
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19266-71. PubMed ID: 20974918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.